The Food and Drug Administration (FDA) on Thursday announced a ban on 36 drugs for the treatment of stomach ulcers, as they have been found to pose a cancer risk.
The ban, which takes effect today, applies to drugs with the active ingredient ranitidine, which contains traces of the contaminant and probable carcinogen N-nitrosodimethylamine (NDMA), the agency said, citing international studies.
The studies also found that the NDMA levels in drugs increase over time and with exposure to heat, sometimes in excess of the maximum acceptable daily intake of 96 nanograms, the FDA said.
Prior to the ban, there were 36 drugs containing ranitidine marketed in Taiwan — 29 prescription drugs and seven over-the-counter medications, the FDA said in a press release.
The ban follows similar decisions by regulators in the US and Europe, where ranitidine products were withdrawn and suspended in April.
Retailers found selling the drugs would be fined between NT$60,000 and NT$1.5 million (US$2,034 and US$50,844) under the Consumer Protection Act (消費者保護法), while those who fail to comply with the recall guidelines risk being fined between NT$200,000 and NT$5 million, the FDA said.
More than 80 million doses of stomach ulcer drugs containing ranitidine are sold in the country each year, National Health Insurance Administration statistics showed.
Taiwanese drug companies on Thursday said that NDMA contamination is usually found in the raw materials used to make the drugs, but does not occur in the production process.
Ranitidine belongs to a family of drugs known as H2 blockers, which include famotidine and cimetidine, two viable substitutes, the companies added.
Two of the holders of drug permit licenses for ranitidine — China Chemical and Pharmaceutical Co and Standard Chemical and Pharmaceutical Co — said they had phased out production of ranitidine last year, after the release of research on its risks.
Yung Shin Pharmaceutical Industrial Co said it has a substitute for ranitidine and is unlikely to be significantly affected by the prohibition.
In 2018, the high blood pressure drug valsartan was recalled globally due to NDMA contamination.
The US’ FDA raised concerns about similar impurities in ranitidine products in September last year, prompting regulators in several countries to place the drug under review.
DIPLOMATIC MOVES: Beijing is reportedly pressing the state after reports of forming links with Taiwan, while the ministry is also planning to reopen its office in Guam soon A representative office is set to open in Somaliland at the end of this month, at the earliest, the Ministry of Foreign Affairs (MOFA) said yesterday amid reports that Beijing is sending a diplomatic delegation to the east African country. The ministry on July 1 announced that Taiwan and Somaliland would establish representative offices, following a report by the Somaliland Chronicle Web site. It said at the time that the two nations did not plan to establish formal ties. Somaliland President Muse Bihi Abdi has instructed close confidants to explore the possibility of “mutual recognition between Taiwan and Somaliland,” the Somaliland Chronicle reported
‘IMMORAL, INSINCERE’: Huang Kun-huei said that Ma was ‘distorting history’ in claiming that Lee Teng-hui laid the foundation for the so-called ‘1992 consensus’ Former Presidential Office secretary-general Huang Kun-huei (黃昆輝) on Saturday rejected former president Ma Ying-jeou’s (馬英九) claim that former president Lee Teng-hui (李登輝) had been a proponent of Beijing’s “one China” principle. Lee, who served as president from 1988 to 2000, died in Taipei on Thursday last week. After visiting the Taipei Guest House on Saturday to pay his respects to Lee, Ma posted on Facebook that “28 years ago on this day” Lee hosted a session of the now-defunct National Unification Council, during which he passed a resolution on the “one China” principle. That resolution became the basis of the Chinese Nationalist Party’s
NEW ERA: Taiwan, which has controlled its virus outbreak, now faces the challenge of safely resuming economic exchanges with other nations, Chang Shan-chwen said People should not focus entirely on having zero new confirmed COVID-19 cases in Taiwan, but neglect overall control over the disease situation, Central Epidemic Command Center (CECC) specialist advisory panel convener Chang Shan-chwen (張上淳) said yesterday. Chang made the remark at a forum in Taipei discussing the steps Taiwan should take in the post-pandemic era, organized by the Chinese-language magazine Global Views Monthly. Chang, Centers for Disease Control (CDC) Director-General Chou Jih-haw (周志浩), and Stanford University’s Center for Policy, Outcomes and Prevention director C. Jason Wang (王智弘) each made a presentation, followed by a panel discussion with Chang, Wang and Buddhist Tzu
A Belgian man who tested positive for COVID-19 in Taiwan last week is likely to have contracted the disease in Taipei in late June, National Taiwan University (NTU) College of Public Health vice dean Tony Chen (陳秀熙) said yesterday. The Central Epidemic Command Center (CECC) on Saturday reported that the man, who is in his 20s, came to Taiwan for work on May 3 and tested positive on Wednesday last week as he was about to depart. The man in March reported loss of taste and smell, the center said, adding that he worked in Changhua County, but visited Taipei several times,